MedPath

COMPARISON OF EFFICACY AND SAFETY OF 2% , SODIUM FUSIDATE VERSUS 2%, MUPIROCIN CREAM VERSUS 1%,OZENOXACIN CREAM AGAINST SKIN AND SOFT TISSUE INFECTIO

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Registration Number
CTRI/2022/09/045863
Lead Sponsor
SIKSHA O ANUSANDHAN university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1-No more than 10 discrete lesions, not exceeding 100 cm2 in total area , or no more than 2% of the total body surface area .

2-All patients above 2 months of age and below 65 yrs of age

3- Skin infection rating scale total score(SIRS) of at least 8.

Exclusion Criteria

. Pregnancy and lactation

2. Signs and symptoms of systemic infections

3.Extensive cellulitis, furunculosis, abscess requiring systemic therapy

5- Immunosuppressed patients.

4- Previous hypersensitivity to any component of either cream , had received a systemic antibacterial or steroid or had applied any topical therapeutic agent directly to skin lesions within the 7 days prior to study entry.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath